Literature DB >> 22511231

Natural course and prognostic factors in patients with mild cervical spondylotic myelopathy with increased signal intensity on T2-weighted magnetic resonance imaging.

Yasushi Oshima1, Atsushi Seichi, Katsushi Takeshita, Hirotaka Chikuda, Takashi Ono, Satoshi Baba, Jiro Morii, Hiroyuki Oka, Hiroshi Kawaguchi, Kozo Nakamura, Sakae Tanaka.   

Abstract

STUDY
DESIGN: A retrospective comparative study.
OBJECTIVE: To investigate natural course and prognostic factors in patients with mild forms of cervical spondylotic myelopathy (CSM), focusing on intramedullary increased signal intensity (ISI) on T2-weighted magnetic resonance imaging. SUMMARY OF BACKGROUND DATA: Long-term natural course of mild forms of CSM, especially with ISI on magnetic resonance imaging, remains uncertain.
METHODS: Patients with CSM who visited our institution between 1992 and 2004 and did not undergo surgery at first visit were retrospectively reviewed. The inclusion criteria were as follows: (1) motor function Japanese Orthopedic Association scores of 3 or more in both upper and lower extremities and (2) cervical spinal cord compression with ISI on T2-weighted magnetic resonance imaging. There were 45 patients, with a mean follow-up period of 78 months (range, 24-208). We investigated long-term natural history by setting the timing of conversion to surgery due to neurological deterioration as an end point. We further compared prognostic parameters between patients who converted to surgery and those who continued to be followed up nonsurgically.
RESULTS: Sixteen patients gradually deteriorated and underwent decompression surgery, whereas 27 patients did not. Apart from these, 2 patients with acute spinal cord injury after minor trauma underwent surgery. Kaplan-Meier survival analysis revealed that 82% or 56% of patients did not require surgery 5 or 10 years after the initial treatment, respectively. As for prognostic factors, Cox proportional hazard analysis revealed that total cervical range of motion (hazard ratio: 3.25), segmental kyphosis in the maximum compression segment (hazard ratio: 4.51), and local slip (hazard ratio: 4.67) were statistically significant.
CONCLUSION: Fifty-six percent of patients with clinically mild CSM with ISI had not deteriorated or undergone surgery at 10 years. Large range of motion, segmental kyphosis, and instability at the narrowest canal were considered to be adverse prognostic factors.

Entities:  

Mesh:

Year:  2012        PMID: 22511231     DOI: 10.1097/BRS.0b013e318259a65b

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  13 in total

1.  Rapid progressive clinical deterioration of cervical spondylotic myelopathy.

Authors:  Y Morishita; A Matsushita; T Maeda; T Ueta; M Naito; K Shiba
Journal:  Spinal Cord       Date:  2014-09-02       Impact factor: 2.772

Review 2.  [Operative treatment of the degenerative cervical spine].

Authors:  A Tschugg; B Meyer; M Stoffel; P Vajkoczy; F Ringel; S-O Eicker; V Rhode; C Thomé
Journal:  Nervenarzt       Date:  2018-06       Impact factor: 1.214

3.  Is the "snake-eye" MRI sign correlated to anterior spinal artery occlusion on CT angiography in cervical spondylotic myelopathy and amyotrophy?

Authors:  Zhengfeng Zhang; Honggang Wang
Journal:  Eur Spine J       Date:  2014-05-14       Impact factor: 3.134

Review 4.  Change in Function, Pain, and Quality of Life Following Structured Nonoperative Treatment in Patients With Degenerative Cervical Myelopathy: A Systematic Review.

Authors:  Lindsay A Tetreault; John Rhee; Heidi Prather; Brian K Kwon; Jefferson R Wilson; Allan R Martin; Ian B Andersson; Anna H Dembek; Krystle T Pagarigan; Joseph R Dettori; Michael G Fehlings
Journal:  Global Spine J       Date:  2017-09-05

5.  Cervical Spondylotic Myelopathy: Natural Course and the Value of Diagnostic Techniques -WFNS Spine Committee Recommendations.

Authors:  Mehmet Zileli; Sachin A Borkar; Sumit Sinha; Rui Reinas; Óscar L Alves; Se-Hoon Kim; Sumeet Pawar; Bala Murali; Jutty Parthiban
Journal:  Neurospine       Date:  2019-09-30

6.  Mir21 modulates inflammation and sensorimotor deficits in cervical myelopathy: data from humans and animal models.

Authors:  Alex M Laliberte; Spyridon K Karadimas; Pia M Vidal; Kajana Satkunendrarajah; Michael G Fehlings
Journal:  Brain Commun       Date:  2021-01-21

7.  Evaluation of conservative treatment and timing of surgical intervention for mild forms of cervical spondylotic myelopathy.

Authors:  Ling-DE Kong; Ling-Chen Meng; Lin-Feng Wang; Yong Shen; Pan Wang; Zi-Kun Shang
Journal:  Exp Ther Med       Date:  2013-07-16       Impact factor: 2.447

8.  Compression Angle of Ossification of the Posterior Longitudinal Ligament and Its Clinical Significance in Cervical Myelopathy.

Authors:  Nam Lee; Do Heum Yoon; Keung Nyun Kim; Hyun Chul Shin; Dong Ah Shin; Yoon Ha
Journal:  J Korean Neurosurg Soc       Date:  2016-09-08

9.  A Clinical Practice Guideline for the Management of Patients With Degenerative Cervical Myelopathy: Recommendations for Patients With Mild, Moderate, and Severe Disease and Nonmyelopathic Patients With Evidence of Cord Compression.

Authors:  Michael G Fehlings; Lindsay A Tetreault; K Daniel Riew; James W Middleton; Bizhan Aarabi; Paul M Arnold; Darrel S Brodke; Anthony S Burns; Simon Carette; Robert Chen; Kazuhiro Chiba; Joseph R Dettori; Julio C Furlan; James S Harrop; Langston T Holly; Sukhvinder Kalsi-Ryan; Mark Kotter; Brian K Kwon; Allan R Martin; James Milligan; Hiroaki Nakashima; Narihito Nagoshi; John Rhee; Anoushka Singh; Andrea C Skelly; Sumeet Sodhi; Jefferson R Wilson; Albert Yee; Jeffrey C Wang
Journal:  Global Spine J       Date:  2017-09-05

Review 10.  The Natural History of Degenerative Cervical Myelopathy and the Rate of Hospitalization Following Spinal Cord Injury: An Updated Systematic Review.

Authors:  Lindsay A Tetreault; Spyridon Karadimas; Jefferson R Wilson; Paul M Arnold; Shekar Kurpad; Joseph R Dettori; Michael G Fehlings
Journal:  Global Spine J       Date:  2017-09-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.